Method for the treatment of disease associated with angiogenesis

The present invention relates to a method of treating disease associated with angiogenesis using an N-Methyl-D-aspartate receptor (NMDA) antagonist. More specifically, it concerns use of an NMDA receptor antagonist, for the treatment of disease associated with angiogenesis such as tumor angiogenesis, ocular neovascular disease, Age-related macular degeneration (AMD).

Keywords: NMDAR antagonist - Target - Angiogenesis
Patent Application number: EP15306894.5
Inventors:
Sébastien DUMASGilles BRU-MERCIERSylvia COHEN-KAMINSKY

Reference:

BIO13165-T1

Business Developper
contact
Anne COCHI
Anne COCHI
Business Development Manager
Patent filling date: 2015-11-30
Second indication: Yes

You might also be interested in